Semustine

Semustine
Clinical data
ATC code	L01AD03 (WHO) ;
Identifiers
	IUPAC name N-(2-Chloroethyl)-N'-(4-methylcyclohexyl)-N-nitrosourea;
CAS Number	13909-09-6 ;
PubChem CID	5198;
UNII	6YY7T1T567;
KEGG	D05822 ;
ChEBI	CHEBI:6863 ;
CompTox Dashboard (EPA)	DTXSID8031603 ;
ECHA InfoCard	100.162.271
Chemical and physical data
Formula	C10H18ClN3O2
Molar mass	247.72 g/mol g·mol−1
	(what is this?) (verify)

Semustine is a drug used in chemotherapy.^[1] It is structurally similar to lomustine, being distinguished from it only by an additional methyl group. It has been taken off the drug market for investigation of its cancerous effects, rated as IARC Group 1 carcinogen or a known carcinogen.^{[citation needed]}

References

^ PMID 1548520

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

[1] PMID 1548520

[1]